Didactic migraine education in US doctor of pharmacy programs

Richard G. Wenzel, Rosalyn S. Padiyara, Jon C. Schommer

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Objective. To compare didactic migraine education in doctor of pharmacy (PharmD) programs in the United States with the Headache Consortium's evidence-based migraine treatment recommendations. Methods. A self-administered survey instrument was mailed to all 90 Accreditation Council for Pharmacy Education (ACPE) approved PharmD programs in the United States. Results. Seventy-seven programs responded (86%) and 69 useable survey instruments were analyzed. Fifty-five percent of programs discussed the Consortium's guidelines, 49% discussed the selection of nonprescription versus prescription agents, 45% recommended a butalbital-containing product as migraine treatment, and 20% educated students about tools for assessing migraine-related debilitation. At least 50% of programs taught information consistent with the remaining Consortium recommendations. Conclusion. Approximately half of the PharmD programs teach concepts about migraine headache treatment consistent with the US Headache Consortium's recommendations.

Original languageEnglish (US)
Pages (from-to)4
Number of pages1
JournalAmerican journal of pharmaceutical education
Issue number1
StatePublished - 2010


  • Evidence-based
  • Headache
  • Migraine
  • Pharmacy education


Dive into the research topics of 'Didactic migraine education in US doctor of pharmacy programs'. Together they form a unique fingerprint.

Cite this